224 related articles for article (PubMed ID: 14627061)
1. Validation of health economic models: the example of EVITA.
Hammerschmidt T; Goertz A; Wagenpfeil S; Neiss A; Wutzler P; Banz K
Value Health; 2003; 6(5):551-9. PubMed ID: 14627061
[TBL] [Abstract][Full Text] [Related]
2. [Impact of universal varicella vaccination in Germany: an epidemiological and economic analysis].
Knuf M; Neiss A; Wutzler P
Klin Padiatr; 2006; 218(4):203-12. PubMed ID: 16819701
[TBL] [Abstract][Full Text] [Related]
3. Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.
Wutzler P; Neiss A; Banz K; Goertz A; Bisanz H
Med Microbiol Immunol; 2002 Oct; 191(2):89-96. PubMed ID: 12410347
[TBL] [Abstract][Full Text] [Related]
4. An economic analysis of the universal varicella vaccination program in the United States.
Zhou F; Ortega-Sanchez IR; Guris D; Shefer A; Lieu T; Seward JF
J Infect Dis; 2008 Mar; 197 Suppl 2():S156-64. PubMed ID: 18419391
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of varicella vaccination in Italian children and adolescents according to different intervention strategies: the burden of uncomplicated hospitalised cases.
Bonanni P; Boccalini S; Bechini A; Banz K
Vaccine; 2008 Oct; 26(44):5619-26. PubMed ID: 18723062
[TBL] [Abstract][Full Text] [Related]
6. Universal mass vaccination against varicella in Germany using an MMRV combination vaccine with a two-dose schedule: an economic analysis.
Hammerschmidt T; Bisanz H; Wutzler P
Vaccine; 2007 Oct; 25(42):7307-12. PubMed ID: 17881097
[TBL] [Abstract][Full Text] [Related]
7. One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?
Lopez AS; Guris D; Zimmerman L; Gladden L; Moore T; Haselow DT; Loparev VN; Schmid DS; Jumaan AO; Snow SL
Pediatrics; 2006 Jun; 117(6):e1070-7. PubMed ID: 16740809
[TBL] [Abstract][Full Text] [Related]
8. The economic value of childhood varicella vaccination in France and Germany.
Coudeville L; Brunot A; Szucs TD; Dervaux B
Value Health; 2005; 8(3):209-22. PubMed ID: 15877593
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.
Valentim J; Sartori AM; de Soárez PC; Amaku M; Azevedo RS; Novaes HM
Vaccine; 2008 Nov; 26(49):6281-91. PubMed ID: 18674582
[TBL] [Abstract][Full Text] [Related]
10. Economic evaluation of varicella vaccination in Spain: results from a dynamic model.
Lenne X; Diez Domingo J; Gil A; Ridao M; Lluch JA; Dervaux B
Vaccine; 2006 Nov; 24(47-48):6980-9. PubMed ID: 16860909
[TBL] [Abstract][Full Text] [Related]
11. Varicella vaccination in Italy : an economic evaluation of different scenarios.
Coudeville L; Brunot A; Giaquinto C; Lucioni C; Dervaux B
Pharmacoeconomics; 2004; 22(13):839-55. PubMed ID: 15329030
[TBL] [Abstract][Full Text] [Related]
12. Coverage, efficacy or dosing interval: which factor predominantly influences the impact of routine childhood vaccination for the prevention of varicella? A model-based study for Italy.
Holl K; Sauboin C; Amodio E; Bonanni P; Gabutti G
BMC Public Health; 2016 Oct; 16(1):1103. PubMed ID: 27769206
[TBL] [Abstract][Full Text] [Related]
13. The cost-effectiveness of routine childhood varicella vaccination in Germany.
Banz K; Wagenpfeil S; Neiss A; Goertz A; Staginnus U; Vollmar J; Wutzler P
Vaccine; 2003 Mar; 21(11-12):1256-67. PubMed ID: 12559807
[TBL] [Abstract][Full Text] [Related]
14. Empirical data on the varicella situation in Germany for vaccination decisions.
Wagenpfeil S; Neiss A; Banz K; Wutzler P
Clin Microbiol Infect; 2004 May; 10(5):425-30. PubMed ID: 15113320
[TBL] [Abstract][Full Text] [Related]
15. [Modelling the impact of vaccination on the epidemiology of varicella zoster virus].
Bonmarin I; Santa-Olalla P; Lévy-Bruhl D
Rev Epidemiol Sante Publique; 2008 Oct; 56(5):323-31. PubMed ID: 18951741
[TBL] [Abstract][Full Text] [Related]
16. How cost effective is universal varicella vaccination in developing countries? A case-study from Colombia.
Paternina-Caicedo A; De la Hoz-Restrepo F; Gamboa-Garay O; Castañeda-Orjuela C; Velandia-González M; Alvis-Guzmán N
Vaccine; 2013 Jan; 31(2):402-9. PubMed ID: 23174195
[TBL] [Abstract][Full Text] [Related]
17. Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.
Tseng HF; Tan HF; Chang CK
Southeast Asian J Trop Med Public Health; 2005 Nov; 36(6):1450-8. PubMed ID: 16610647
[TBL] [Abstract][Full Text] [Related]
18. Varicella vaccination coverage inverse correlation with varicella hospitalizations in Spain.
Gil-Prieto R; Garcia-Garcia L; San-Martin M; Gil-de-Miguel A
Vaccine; 2014 Dec; 32(52):7043-6. PubMed ID: 25444825
[TBL] [Abstract][Full Text] [Related]
19. Impact of universal vaccination on the epidemiology of varicella in Veneto, Italy.
Pozza F; Piovesan C; Russo F; Bella A; Pezzotti P; Emberti Gialloreti L
Vaccine; 2011 Nov; 29(51):9480-7. PubMed ID: 22015389
[TBL] [Abstract][Full Text] [Related]
20. Assessing the introduction of universal varicella vaccination in the Netherlands.
Boot HJ; de Melker HE; Stolk EA; de Wit GA; Kimman TG
Vaccine; 2006 Sep; 24(37-39):6288-99. PubMed ID: 16790302
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
